Eads & Heald Wealth Management’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Sell
3,057
-140
-4% -$96.8K 1.04% 38
2025
Q4
$1.82M Sell
3,197
-63
-2% -$36.6K 0.88% 47
2025
Q3
$1.99M Sell
3,260
-18
-0.5% -$10.2K 0.95% 42
2025
Q2
$1.64M Sell
3,278
-88
-3% -$43.3K 0.81% 50
2025
Q1
$1.72M Sell
3,366
-47
-1% -$22.4K 0.88% 52
2024
Q4
$1.6M Sell
3,413
-25
-0.7% -$12.6K 0.79% 57
2024
Q3
$1.81M Sell
3,438
-253
-7% -$124K 0.86% 48
2024
Q2
$1.61M Sell
3,691
-7
-0.2% -$3.2K 0.78% 56
2024
Q1
$1.77M Sell
3,698
-137
-4% -$63.1K 0.83% 54
2023
Q4
$1.79M Sell
3,835
-28
-0.7% -$13.1K 0.86% 53
2023
Q3
$1.7M Sell
3,863
-31
-0.8% -$13.6K 0.89% 48
2023
Q2
$1.77M Sell
3,894
-172
-4% -$78K 0.87% 50
2023
Q1
$1.88M Sell
4,066
-98
-2% -$45.5K 0.93% 48
2022
Q4
$2.27M Sell
4,164
-40
-1% -$20.9K 1.16% 33
2022
Q3
$1.98M Sell
4,204
-180
-4% -$85.8K 1.12% 37
2022
Q2
$2.1M Sell
4,384
-324
-7% -$149K 1.13% 35
2022
Q1
$2.1M Sell
4,708
-149
-3% -$61.5K 0.98% 48
2021
Q4
$1.88M Sell
4,857
-17
-0.3% -$6.33K 0.82% 58
2021
Q3
$1.75M Buy
4,874
+22
+0.5% +$7.95K 0.85% 56
2021
Q2
$1.76M Sell
4,852
-5
-0.1% -$1.8K 0.86% 57
2021
Q1
$1.57M Buy
4,857
+200
+4% +$60.3K 0.81% 64
2020
Q4
$1.42M Buy
4,657
+228
+5% +$69.8K 0.76% 63
2020
Q3
$1.4M Buy
4,429
+63
+1% +$20.5K 0.84% 57
2020
Q2
$1.34M Buy
4,366
+814
+23% +$267K 0.82% 62
2020
Q1
$1.07M Sell
3,552
-412
-10% -$143K 0.76% 64
2019
Q4
$1.36M Sell
3,964
-41
-1% -$14.4K 0.72% 65
2019
Q3
$1.5M Sell
4,005
-314
-7% -$111K 0.84% 59
2019
Q2
$1.4M Sell
4,319
-133
-3% -$39.6K 0.79% 61
2019
Q1
$1.2M Buy
4,452
+343
+8% +$93.6K 0.69% 66
2018
Q4
$1.01M Buy
4,109
+186
+5% +$51.4K 0.67% 66
2018
Q3
$1.25M Buy
3,923
+10
+0.3% +$3.05K 0.71% 68
2018
Q2
$1.2M Sell
3,913
-97
-2% -$32.1K 0.74% 65
2018
Q1
$1.4M Sell
4,010
-470
-10% -$157K 0.89% 51
2017
Q4
$1.38M Sell
4,480
-101
-2% -$30.3K 0.81% 58
2017
Q3
$1.32M Sell
4,581
-122
-3% -$32.8K 0.82% 60
2017
Q2
$1.21M Sell
4,703
-273
-5% -$68.3K 0.77% 66
2017
Q1
$1.18M Sell
4,976
-46
-0.9% -$10.9K 0.76% 68
2016
Q4
$1.17M Sell
5,022
-289
-5% -$67.2K 0.8% 63
2016
Q3
$1.14M Sell
5,311
-17
-0.3% -$3.68K 0.78% 64
2016
Q2
$1.18M Sell
5,328
-633
-11% -$133K 0.81% 60
2016
Q1
$1.18M Sell
5,961
-684
-10% -$129K 0.82% 63
2015
Q4
$1.25M Sell
6,645
-229
-3% -$42K 0.87% 58
2015
Q3
$1.14M Sell
6,874
-390
-5% -$65.4K 0.81% 61
2015
Q2
$1.15M Sell
7,264
-231
-3% -$37K 0.76% 63
2015
Q1
$1.21M Sell
7,495
-990
-12% -$158K 0.78% 61
2014
Q4
$1.25M Sell
8,485
-386
-4% -$52.9K 0.8% 62
2014
Q3
$1.17M Sell
8,871
-147
-2% -$18.6K 0.79% 62
2014
Q2
$1.08M Sell
9,018
-403
-4% -$48.7K 0.72% 68
2014
Q1
$1.16M Sell
9,421
-901
-9% -$107K 0.76% 62
2013
Q4
$1.18M Sell
10,322
-1,170
-10% -$125K 0.79% 62
2013
Q3
$1.09M Sell
11,492
-2,528
-18% -$234K 0.78% 65
2013
Q2
$1.16M Buy
+14,020
New +$1.09M 0.82% 61

Other funds holding NOC

Eads & Heald Wealth Management's NOC Position: Q1 2026 in Review

Eads & Heald Wealth Management reduced its Northrop Grumman (NOC) stake by 4.4% in Q1 2026, selling an estimated $96.8K and leaving 3,057 shares worth $2.09M. The position accounts for 1.04% of the portfolio, ranked #38.

Eads & Heald Wealth Management first reported a position in NOC in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.27M in Q4 2022. 1,875 funds tracked by Wall St. Rank hold NOC as of Q1 2026.

  • Eads & Heald Wealth Management held 3,057 shares of Northrop Grumman worth $2.09M as of Q1 2026.
  • Eads & Heald Wealth Management sold 140 Northrop Grumman shares in Q1 2026, an estimated $96.8K.
  • Northrop Grumman made up 1.04% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #38 holding.
  • Eads & Heald Wealth Management first reported a position in Northrop Grumman in Q2 2013 and has held it in 52 quarters since.
  • Eads & Heald Wealth Management's Northrop Grumman position peaked at $2.27M in Q4 2022.
  • 1,875 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.